• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

Can LSD Make You Smarter? New Study Shows Positive Results

Emma Stone by Emma Stone
October 18, 2022
in Science
Reading Time: 4 mins read
A A
New Study Shows Ketamine’s Fast-Acting Effects on Depression

Humans are always on the hunt for life hacks, whether it’s getting fitter, slimmer, or more beautiful. The actual effects of varied elixirs, potions and pills in fast-tracking such states remains, however, negligible. But what about the quest for increased intelligence? Can psychedelics like LSD make you smarter?

As the psychedelic renaissance picks up momentum, evidence is emerging that these potent mind-altering compounds may in fact stimulate the brain in diverse ways.

“Psychedelics have a profound and global impact on human cognition and neurochemistry,” said Derek Chase, founder of Psilouette.

“The most often cited and exciting paradigm shifts psychedelics hold for brain function are their impact on neurogenesis, or the creation of new neurons. Psychedelics show efficacy in promoting new neuron growth as well as neuroplasticity, which combine to provide a major upleveling in learning and memory while staving off the cognitive decline caused by biological aging.”

[bsa_pro_ad_space id=2]
ADVERTISEMENT

While most psychedelic substances have been linked to brain-boosting properties, emerging evidence suggests that LSD may be a particularly potent nootropic or cognitive enhancer. A October 2022 study found that a single dose of LSD could boost neural plasticity and enhance cognition in humans several days after administration.

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development

 

 

 

New study looks at LSD’s effect on the brain

To investigate how LSD affected the brain, the researchers’ approach was threefold and mapped the effects of the psychedelic at molecular, behavioral, and computational levels.

On the molecular front, brain organoids grown from human stem cell tissue showed that LSD influenced neural plasticity.

“Notably, we found significant LSD-induced changes in the mTOR pathway, a protein kinase involved in multiple neural plasticity events, acting as a hub between plasticity, learning, and memory,” said the researchers. LSD was also found to enhance synaptogenesis, or the formation of synapses that create brain networks and enhance brain connectivity.

The researchers also explored the behavioral effects of LSD on 76 rats. After administering a dose of LSD or placebo, the rats were then exposed to a novel object preference task several days later. The animals that had received LSD were substantially more likely to seek out and engage with novel objects. A motivation to engage with novel objects means that the memory of the familiar object remains, so the animal is more compelled to explore the novel object as they are curious about the unknown.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

“Psychedelics show efficacy in promoting new neuron growth as well as neuroplasticity, which combine to provide a major upleveling in learning and memory while staving off the cognitive decline caused by biological aging.”

 

The human participant-focused component of the research investigated the effects of a 50 μg of LSD and 50 μg of an inactive placebo on 25 volunteers. The volunteers completed several tests the day after dosing to explore how the psychedelic impacted memory consolidation, encoding (the process by which new information is converted and stored in the brain) and recall. The researchers found that LSD, compared to placebo, improved memory performance on all three fronts.

“In the morning after LSD dosing, the percentage of recalled card locations was increased, indicating overnight memory consolidation,” they commented in the article. LSD appeared to enhance photographic memory and support spontaneous recall, but not enduring recall (remembering something 20-30 minutes after being exposed to it).

Nuance in the research findings also suggested that the effects of the psychedelic were influenced by the dose, age, and cognitive domain of the participant. The results indicated that LSD affected memory consolidating, encoding, and recall differently, depending on age.

“Future studies should carefully disentangle dose-dependent effects in different subacute stages and age groups concerning the effects across different age groups,” the researchers recommended.

Finally, the researchers created a computational neural network model to gain deeper insights into how LSD induced increased interest in novel objects in rats and enhanced memory in humans. The computational model suggested that the beneficial effects of LSD peak at a certain dose, and that performance and plasticity could start tapering off at higher doses.

 

 

LSD may increase brain functions, but dose and intention matters

Purchase Quick Lasix Online

Overall, the researchers emphasized that LSD may enhance cognitive function and neuroplasticity via its effects on the mTOR pathway, one of the most critical pathways that regulate aging in the brain. A disturbance in mTOR levels has been associated with Alzheimer’s disease, indicating a close relationship between the pathway and neurodegenerative disorders.

“The mTOR pathway is a master metabolic regulator that specifically deals with energy production,” says Chase.

“This study shows that LSD stimulates the mTOR pathway, and infers that it is responsible for its cognitive performance gains. This makes a ton of sense, since mTOR is responsible for energy production within our cells, and enhanced energy would equate to faster processing time and a host of other neurological benefits.”

However, other biochemical mechanisms may be at work too, particularly when it comes to the age-dependent effects of LSD.

“Another potential mechanism underlying the age-dependence of the nootropic effect of LSD is the progressive reduction in the expression of serotonin receptors as people age,” said the researchers.

Chase believes the nootropic capacity of LSD can best be harnessed by working with the compound in a mindful, intentional way.

 

“LSD, only when combined with a strong intention, will enhance one’s innate capacity for learning and memory by altering both neurochemistry and neuro-anatomy, resulting in a smarter and more creative individual.”

 

“The most important principles we communicate to our clients about psychedelic-assisted therapies is that a strong intention creates the foundation for the therapeutic benefit, and that immediate and long-term integrative work allows the lessons learned during the psychedelic experience to stick.”

Interested in more like this? Check out New Study Looks at Psychedelics and Near-Death Experiences

Tags: LSDscience
Emma Stone

Emma Stone

Hi there! I'm a journalist specializing in cannabis and psychedelics. I also hold a PhD in sociology, which has served me well when it comes to researching scholarly material and communicating it in an engaging, accessible way. I'd welcome the opportunity to contribute to Microdose on a regular basis, and have included some relevant recent samples of my writing below. Looking forward to hearing from you, Warmly, Emma

Next Post
MindMed Releases Phase 1 Trial Results For Opioid Addiction

Top 5 Psychedelic Clinical Trials in 2022

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.